查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球兽医皮肤病学市场按给药途径、产品类型、疾病状况、动物类型、最终用户和地区划分 - 预测至 2030 年
市场调查报告书
商品编码
1669769

全球兽医皮肤病学市场按给药途径、产品类型、疾病状况、动物类型、最终用户和地区划分 - 预测至 2030 年

Veterinary Dermatology Market by Route of Administration, Product type, Condition type, Animal type - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 385 Pages | 订单完成后即时交付

价格

全球兽医皮肤病学市场预计将从 2025 年的 201.1 亿美元成长到 2030 年的 303.1 亿美元，预测期内的复合年增长率为 8.5%。

由于伴同性动物数量的扩大和宠物拥有量的增加，兽医皮肤病学市场正在经历显着的增长。人们对通用感染疾病的担忧日益加剧，进一步影响了皮肤病治疗的需求。政府和动物福利组织积极提高宣导活动并鼓励对宠物和牲畜的皮肤病进行早期诊断和治疗。此外，宠物保险的日益普及和兽医医疗费用的上涨也透过改善获得专门皮肤病治疗的机会来支持市场成长。然而，也存在一些挑战，例如宠物医疗费用的上涨限制了治疗的广泛使用。此外，杀虫剂的抗药性不断增强以及常见皮肤病治疗效果的降低也令人担忧。儘管有这些市场限制，兽医皮肤病学的进步，包括新型治疗剂和诊断技术，继续推动市场机会。

研究范围
调查年份 2023-2030
基准年 2023
预测期 2025-2030
考虑单位 金额（美元）
按细分市场 依给药途径、依产品类型、依疾病状况、动物类型、依最终使用者、按地区
目标区域 北美、欧洲、亚太地区、中东和非洲（海湾合作委员会国家）

由于给药方便且宠物饲主的依从性提高，口服製剂领域预计在 2025-2030 年预测期内的复合年增长率最高。锭剂、胶囊和咀嚼片等口服药物是外用药物或註射药物的便利治疗方法。越来越多的兽医建议全身治疗而非局部用药，而且开发出更偏好的配方，这推动了需求的成长。此外，缓释性口服製剂等药物传递系统的进步也促进了兽医皮肤病学市场这一领域的成长。

由于动物寄生虫感染的盛行率不断上升，抗寄生虫药物部门在 2024 年占据了最大的市场占有率。这些药物包括跳蚤和蜱虫预防剂，广泛用于治疗和预防。宠物拥有量的增加和对通用感染疾病认知的不断提高正在推动对抗寄生虫药物的需求。此外，针对多种寄生虫的联合治疗的出现也推动了市场扩张。业界的主要企业推出了创新配方，以提供更高的功效和更长的保护，进一步巩固了他们在这一领域的主导地位。

预计寄生虫感染疾病将在兽医皮肤病学市场中出现最快的成长率。由于宠物中跳蚤、蜱虫和螨虫的感染率很高，特别是在温暖、潮湿的气候下，对有效治疗的需求也日益增长。寄生虫性皮肤炎会引起剧烈搔痒、脱髮和继发细菌感染，增加兽医治疗的需要。诊断方法的进步以及处方药和非处方药治疗的日益普及促进了这一领域的快速增长。此外，饲主对寄生虫预防意识的不断增强也进一步推动了市场的扩张。

由于宠物拥有量的增加和动物保健支出的增加，伴同性动物领域在 2024 年占据了最大的市场占有率。狗和猫极易患上过敏、真菌感染疾病和外部寄生虫感染疾病等皮肤病，需要经常进行皮肤病治疗。宠物人性化的日益增长的趋势和对优质兽医护理的需求进一步推动了市场的成长。此外，包括生物製药和标靶治疗在内的皮肤病学药物的进步正在改善伴同性动物的治疗效果，加强了该领域在市场上的主导地位。

本报告研究了全球兽医皮肤病学市场，并按给药途径、产品类型、疾病状态、动物类型、最终用户、区域趋势和公司概况对市场份额、收入和销售额进行了详细分析。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章 市场概况

  • 介绍
  • 市场动态
  • 产业趋势
  • 技术分析
  • 波特五力分析
  • 监管状态
  • 专利分析
  • 贸易分析
  • 定价分析
  • 报销分析
  • 重要会议及活动
  • 主要相关人员和采购标准
  • 兽医皮肤病学市场中未满足的需求/最终用户期望
  • 生成式人工智慧对兽医皮肤病学市场的影响
  • 生态系分析
  • 案例研究分析
  • 供应链分析
  • 价值链分析
  • 动物皮肤病学市场的邻近市场
  • 影响客户业务的趋势/中断
  • 投资金筹措场景

6. 兽医皮肤科市场，依给药途径划分

  • 介绍
  • 局部药物
  • 注射
  • 口服

第七章。

  • 介绍
  • 抗寄生虫药
  • 抗真菌剂
  • 抗菌剂
  • 单株抗体
  • 其他的

第 8 章。

  • 介绍
  • 寄生虫感染疾病
  • 感染疾病
  • 自体免疫皮肤病
  • 皮肤癌
  • 其他的

第九章。

  • 介绍
  • 宠物
  • 家畜

第 10 章。

  • 介绍
  • 兽医医院和诊所
  • 动物收容所和救援
  • 其他的

第 11 章。

  • 介绍
  • 北美洲
    • 宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 宏观经济展望
    • 德国
    • 英国
    • 法国
    • 义大利
    • 瑞士
    • 西班牙
    • 其他的
  • 亚太地区
    • 宏观经济展望
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他的
  • 拉丁美洲
    • 宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 宏观经济展望
    • 海湾合作委员会国家
    • 其他的

第十二章 竞争格局

  • 概述
  • 主要参与企业的策略/优势
  • 动物皮肤病学市场主要企业的收益分析（2020-2024）
  • 2024 年市场占有率分析
  • 公司估值矩阵：主要参与企业，2024 年
  • 公司估值矩阵：Start-Ups/中小企业，2024 年
  • 品牌/产品比较
  • 主要企业研发支出
  • 企业估值与财务指标
  • 竞争场景

第十三章 公司简介

  • 主要参与企业
    • ELANCO ANIMAL HEALTH INCORPORATED
    • MERCK & CO., INC
    • VIRBAC
    • ZOETIS INC.
    • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    • VETOQUINOL
    • DECHRA PHARMACEUTICALS PLC
    • HESTER BIOSCIENCES LIMITED
    • PETIQ, INC.
    • OUROFINO SAUDE ANIMAL
    • SWEDENCARE
    • ORION CORPORATION
    • NORBROOK
    • CEVA SANTE ANIMALE
    • BIMEDA, INC.
  • 其他公司
    • INDIAN IMMUNOLOGICALS LTD.
    • VETANCO
    • CHANELLE PHARMA
    • PEGASUS LABORATORIES, INC.
    • KYORITSU SEIYAKU CORPORATION
    • AVET HEALTH
    • ANIMALDERMA SRLS
    • LETI PHARMA
    • HUVEPHARMA, INC.
    • VETPLUS

第十四章 附录

Product Code: MD 9319

The global veterinary dermatology market is projected to reach USD 30.31 billion by 2030 from USD 20.11 billion in 2025, at a CAGR of 8.5% during the forecast period. The Veterinary Dermatology Market is experiencing significant growth, driven by the expanding companion animal population and increasing pet ownership. Growing concerns about infectious zoonotic diseases have further influenced the demand for dermatological treatments. Government and animal welfare organizations are actively promoting awareness initiatives, encouraging early diagnosis and treatment of dermatological conditions in both pets and farm animals. Moreover, the rising adoption of pet insurance and high animal healthcare expenditure are supporting market growth by improving access to specialized dermatological care. However, the market faces challenges such as the rising cost of pet care, which can limit treatment adoption. Additionally, increasing resistance to parasiticides poses a significant concern, reducing the effectiveness of common dermatological treatments. Despite these restraints, advancements in veterinary dermatology, including novel therapeutics and diagnostic techniques, continue to drive market opportunities.

Scope of the Report
Years Considered for the Study2023-2030
Base Year2023
Forecast Period2025-2030
Units ConsideredValue (USD)
SegmentsBy Route of Administration By Product,By Condition Type, By Animal Type, By End user, By Region
Regions coveredNorth America, Europe, APAC, LATAM, Middle East & Africa (GCC countries)

"The Oral segment is projected to grow at the highest CAGR during the forecast period of 2025-2030."

The oral segment is projected to grow at the highest CAGR during 2025-2030 due to its ease of administration and improved pet owner compliance. Oral medications, including tablets, capsules, and chewable formulations, offer a convenient alternative to topical and injectable treatments. Increasing veterinary recommendations for systemic treatments over topical solutions and the development of palatable formulations are boosting demand. Additionally, advancements in drug delivery systems, such as sustained-release oral formulations, contribute to the segment's growth in the veterinary dermatology market.

"Antiparasitic Drugs segment accounted the largest market in 2024 in veterinary dermatology market."

The antiparasitic drugs segment accounted for the largest market share in 2024 due to the rising prevalence of parasitic infections in animals. These drugs, including flea and tick preventives, are widely used for both treatment and prevention. Increasing pet adoption and awareness about zoonotic diseases are fueling the demand for antiparasitic treatments. Moreover, the growing availability of combination therapies that target multiple parasites has driven market expansion. Key industry players are launching innovative formulations with improved efficacy and longer protection durations, further strengthening the segment's dominance.

" Parasitic infection is expected to witness the fastest growth rate in the global veterinary dermatology market."

Parasitic infections are expected to witness the fastest growth rate in the veterinary dermatology market. The high incidence of flea, tick, and mite infestations in pets, especially in warm and humid regions, is driving demand for effective treatments. Parasitic dermatitis can cause severe itching, hair loss, and secondary bacterial infections, increasing the need for veterinary care. Advancements in diagnostic methods and increasing availability of prescription and over-the-counter treatments contribute to the segment's rapid growth. Moreover, heightened pet owner awareness of parasite prevention further supports market expansion.

"Companion animals segment has accounted the largest market share in the veterinary dermatology market."

The companion animals segment accounted for the largest market share in 2024, driven by increasing pet ownership and growing expenditure on animal healthcare. Dogs and cats are highly susceptible to skin conditions such as allergies, fungal infections, and ectoparasitic infestations, necessitating frequent dermatological treatments. The rising trend of pet humanization and demand for premium veterinary care further boost market growth. Additionally, advancements in dermatological therapeutics, including biologics and targeted therapies, enhance treatment outcomes for companion animals, reinforcing the segment's dominance in the market.

"Veterinary Hospitals and Clinics segment is expected to witness the highest growth rate in the global veterinary dermatology market."

Veterinary hospitals and clinics are expected to witness the highest growth rate, driven by the increasing number of veterinary visits and the availability of specialized dermatology services. These facilities provide comprehensive treatment options, including advanced diagnostics, prescription medications, and surgical interventions for severe skin conditions. The rise in dermatology-focused veterinary clinics and expansion of telemedicine services for dermatological consultations contribute to segment growth. Additionally, pet insurance coverage for dermatological treatments encourages pet owners to seek veterinary care, further increasing demand in this segment.

"North America has accounted for the largest market share in 2024."

North America accounted for the largest market share in 2024, supported by a well-established veterinary healthcare infrastructure and high pet ownership rates. The region has a strong presence of leading market players investing in research and development for innovative dermatological treatments. Rising awareness about pet skin health, coupled with increasing spending on veterinary care, drives market expansion. Additionally, the growing demand for premium pet dermatology products, including hypoallergenic shampoos, medicated sprays, and prescription drugs, contributes to North America's market dominance in the global veterinary dermatology industry.

Breakdown of supply-side primary interviews: * By Company Type: Tier 1 - 45%, Tier 2 - 20%, and Tier 3 - 35% * By Designation: C-level - 35%, Director-level - 25%, and Others - 40% * By Region: North America - 40%, Europe - 25%, APAC - 20%, Latin America - 10%, Middle East & Africa - 5%

Breakdown of demand-side primary interviews: * By Company Type: Vterinary Hospitals and Clinics - 55%, Animal Shelters and Clinics - 30%, and Other End Users - 15% * By Designation: Veterinary Professionals - 35%, Pet Owners - 30%, Livestock Farmers - 25% and Governtment Officers - 10% * By Region: North America - 40%, Europe - 25%, APAC - 20%, Latin America - 10%, Middle East & Africa - 5%

Research Coverage

This report studies veterinary dermatology market based on route of administration, product types, condition types, animal types, end users, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions and respective countries.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:

  • Analysis of key drivers (Expanding companion animal population and pet ownership, Growing concerns about infectious zoonotic diseases, Rising Awareness initiatives by government and animal welfare organizations, Increasing adoption of pet insurance and high animal healthcare expenditure), restraints (Rising pet care costs, Restrictions on use of parasiticides for food-producing animals), opportunities (Technological advancements and product launches, High growth potential in emerging economies, Surging number of veterinary practitioners in developed markets), and challenges (Growing resistance to parasiticides, Diversity in parasite species) influencing the growth of veterinary dermatology market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in veterinary dermatology market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of veterinary dermatology treatments across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in veterinary dermatology market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in veterinary dermatology market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
  • 2.7 RESEARCH LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN VETERINARY DERMATOLOGY MARKET
  • 4.2 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET OVERVIEW
  • 4.3 VETERINARY DERMATOLOGY MARKET: REGIONAL MIX
  • 4.4 VETERINARY DERMATOLOGY MARKET, BY COUNTRY
  • 4.5 VETERINARY DERMATOLOGY MARKET: EMERGING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Expanding companion animal population and pet ownership
      • 5.2.1.2 Growing concerns about infectious zoonotic diseases
      • 5.2.1.3 Rising awareness initiatives by government and animal welfare organizations
      • 5.2.1.4 Increasing adoption of pet insurance and high animal healthcare expenditure
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Rising pet care costs
      • 5.2.2.2 Restrictions on use of parasiticides for food-producing animals
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Technological advancements and product launches
      • 5.2.3.2 High growth potential in emerging economies
      • 5.2.3.3 Surging number of veterinary practitioners in developed markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Growing resistance to parasiticides
      • 5.2.4.2 Diversity in parasite species
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 RISE IN PET OWNERSHIP, HUMANIZATION OF PETS, AND INCREASED FOCUS ON PET WELLNESS PROGRAMS
    • 5.3.2 RISING USE OF DIAGNOSTICS AND WEARABLE TECHNOLOGY FOR EARLY DETECTION
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 Topical nanomedicine
      • 5.4.1.2 Biologic therapies
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 Phototherapy
      • 5.4.2.2 Hydrotherapy
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 Telemedicine platforms
      • 5.4.3.2 Wearable devices
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 COMPETITIVE RIVALRY
      • 5.5.1.1 Established players
      • 5.5.1.2 Continuous innovation
    • 5.5.2 BARGAINING POWER OF BUYERS
      • 5.5.2.1 Consolidated veterinary groups
      • 5.5.2.2 Demand for affordable solutions
    • 5.5.3 BARGAINING POWER OF SUPPLIERS
      • 5.5.3.1 Specialized raw materials
      • 5.5.3.2 Quality compliance
    • 5.5.4 THREAT OF SUBSTITUTES
      • 5.5.4.1 Limited alternatives
      • 5.5.4.2 Specialized treatments
    • 5.5.5 THREAT OF NEW ENTRANTS
      • 5.5.5.1 High R&D costs
      • 5.5.5.2 Regulatory requirements
  • 5.6 REGULATORY LANDSCAPE
    • 5.6.1 REGULATORY ANALYSIS
    • 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7 PATENT ANALYSIS
    • 5.7.1 PATENT PUBLICATION TRENDS FOR VETERINARY DERMATOLOGY MARKET
    • 5.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.8 TRADE ANALYSIS
    • 5.8.1 IMPORT AND EXPORT SCENARIO FOR VETERINARY DERMATOLOGY PRODUCTS
  • 5.9 PRICING ANALYSIS
    • 5.9.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT TYPE
    • 5.9.2 AVERAGE SELLING PRICE TREND OF VETERINARY DERMATOLOGY PRODUCT TYPES, BY REGION
  • 5.10 REIMBURSEMENT ANALYSIS
  • 5.11 KEY CONFERENCES AND EVENTS
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.12.2 BUYING CRITERIA
  • 5.13 UNMET NEEDS/END USER EXPECTATIONS IN VETERINARY DERMATOLOGY MARKET
  • 5.14 IMPACT OF GENERATIVE AI ON VETERINARY DERMATOLOGY MARKET
  • 5.15 ECOSYSTEM ANALYSIS
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 ZOETIS LAUNCHED APOQUEL TABLET FOR ALLERGIC DERMATITIS
    • 5.16.2 ELANCO LAUNCHED ZENRELIA TABLET FOR CANINE ATOPIC DERMATITIS
    • 5.16.3 VIRBAC LAUNCHED ALLERDERM SPOT-ON TOPICAL PRODUCT FOR SKIN BARRIER REPAIR
  • 5.17 SUPPLY CHAIN ANALYSIS
  • 5.18 VALUE CHAIN ANALYSIS
  • 5.19 ADJACENT MARKETS FOR VETERINARY DERMATOLOGY MARKET
  • 5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.21 INVESTMENT AND FUNDING SCENARIO

6 VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION

  • 6.1 INTRODUCTION
  • 6.2 TOPICAL
    • 6.2.1 HIGH PREVALENCE OF ECTOPARASITIC INFESTATIONS AMONG PETS TO DRIVE DEMAND
  • 6.3 INJECTABLES
    • 6.3.1 RAPID ABSORPTION AND HIGH BIOAVAILABILITY TO FUEL GROWTH OF INJECTABLE PRODUCTS
  • 6.4 ORAL
    • 6.4.1 COMPREHENSIVE APPROACH TO MANAGING CHRONIC AND SEVERE DERMATOLOGICAL DISORDERS

7 VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE

  • 7.1 INTRODUCTION
  • 7.2 ANTIPARASITIC DRUGS
    • 7.2.1 HIGH PREVALENCE OF PARASITIC INFECTIONS IN ANIMALS TO DRIVE DEMAND
  • 7.3 ANTIFUNGAL DRUGS
    • 7.3.1 INCREASING INSTANCES OF YEAST DERMATITIS AND CANDIDIASIS TO DRIVE DEMAND
  • 7.4 ANTIBACTERIAL DRUGS
    • 7.4.1 GROWTH HINDERED BY RISING CONCERNS OVER ANTIMICROBIAL RESISTANCE
  • 7.5 MONOCLONAL ANTIBODIES
    • 7.5.1 RISING INVESTMENT IN R&D TO BOOST SEGMENTAL GROWTH
  • 7.6 OTHER PRODUCT TYPES

8 VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE

  • 8.1 INTRODUCTION
  • 8.2 PARASITIC INFECTIONS
    • 8.2.1 HIGH OCCURRENCE IN BOTH COMPANION AND LIVESTOCK ANIMALS TO DRIVE DEMAND FOR PREVENTIVE MEASURES
  • 8.3 INFECTIOUS DISEASES
    • 8.3.1 HIGH PREVALENCE OF FUNGAL INFECTIONS TO DRIVE GROWTH
  • 8.4 AUTOIMMUNE SKIN DISEASES
    • 8.4.1 LOWER OCCURRENCE OF THESE DISEASES CONTRIBUTE TO SMALLER MARKET SHARE
  • 8.5 SKIN CANCER
    • 8.5.1 GROWING AWARENESS ABOUT IMPORTANCE OF EARLY DETECTION AND TREATMENT OF SKIN CANCER TO DRIVE GROWTH
  • 8.6 OTHER CONDITION TYPES

9 VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE

  • 9.1 INTRODUCTION
  • 9.2 COMPANION ANIMALS
    • 9.2.1 DOGS
      • 9.2.1.1 Growing dog population and high pet ownership to drive growth
    • 9.2.2 CATS
      • 9.2.2.1 Growing awareness of feline health to drive growth
    • 9.2.3 HORSES
      • 9.2.3.1 Initiatives related to adoption to drive growth
    • 9.2.4 OTHER COMPANION ANIMALS
  • 9.3 LIVESTOCK ANIMALS
    • 9.3.1 CATTLE
      • 9.3.1.1 Economic importance of dairy and beef cattle to drive growth
    • 9.3.2 SWINE
      • 9.3.2.1 Rising global swine population and pork consumption to drive growth
    • 9.3.3 POULTRY
      • 9.3.3.1 Increasing demand for milk and dairy products to drive growth
    • 9.3.4 OTHER LIVESTOCK ANIMALS

10 VETERINARY DERMATOLOGY MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 VETERINARY HOSPITALS AND CLINICS
    • 10.2.1 GROWING DEMAND FOR SPECIALIZED SKINCARE AND TREATMENTS TO DRIVE MARKET
  • 10.3 ANIMAL SHELTERS AND RESCUES
    • 10.3.1 NGO AND ANIMAL WELFARE ORGANIZATIONS TO KEEP SUPPORTING DERMATOLOGICAL TREATMENT IN VETERINARY MARKET
  • 10.4 OTHER END USERS

11 VETERINARY DERMATOLOGY MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK
    • 11.2.2 US
      • 11.2.2.1 High pet ownership rates to drive growth
    • 11.2.3 CANADA
      • 11.2.3.1 Rising concerns about pet skin health to drive market
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK
    • 11.3.2 GERMANY
      • 11.3.2.1 Rising poultry consumption and dairy industry to drive market
    • 11.3.3 UK
      • 11.3.3.1 Large pet ownership and zoonotic disease prevention to drive market
    • 11.3.4 FRANCE
      • 11.3.4.1 Stable animal healthcare spending to support market growth
    • 11.3.5 ITALY
      • 11.3.5.1 Expanding livestock industry to drive market
    • 11.3.6 SWITZERLAND
      • 11.3.6.1 High standards in animal health to drive growth
    • 11.3.7 SPAIN
      • 11.3.7.1 Growing pet population and strong dairy industry to drive market
    • 11.3.8 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK
    • 11.4.2 JAPAN
      • 11.4.2.1 Rising demand for animal products and increasing pet ownership to drive growth
    • 11.4.3 CHINA
      • 11.4.3.1 Expanding urban pet market and high meat consumption to fuel market
    • 11.4.4 INDIA
      • 11.4.4.1 Growing pet adoption and veterinary shortage to drive market
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 Growing pet ownership and rising spending on veterinary care to drive market
    • 11.4.6 NEW ZEALAND
      • 11.4.6.1 Increased pet ownership and demand for advanced dermatology treatments to drive market
    • 11.4.7 SOUTH KOREA
      • 11.4.7.1 Increasing awareness and adoption of preventive healthcare measures to drive market
    • 11.4.8 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK
    • 11.5.2 BRAZIL
      • 11.5.2.1 Strong veterinary infrastructure and expanding livestock industry to drive market
    • 11.5.3 MEXICO
      • 11.5.3.1 Expanding livestock and poultry sectors to drive market
    • 11.5.4 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 MACROECONOMIC OUTLOOK
    • 11.6.2 GCC COUNTRIES
      • 11.6.2.1 Kingdom of Saudi Arabia (KSA)
        • 11.6.2.1.1 Vision 2030 investments to drive market
      • 11.6.2.2 United Arab Emirates (UAE)
        • 11.6.2.2.1 Significant livestock population to fuel demand
      • 11.6.2.3 Rest of GCC Countries
    • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 12.3 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2020-2024)
  • 12.4 MARKET SHARE ANALYSIS, 2024
    • 12.4.1 RANKING OF KEY MARKET PLAYERS, 2024
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Region footprint
      • 12.5.5.3 Route of administration footprint
      • 12.5.5.4 Product type footprint
      • 12.5.5.5 Condition type footprint
      • 12.5.5.6 Animal type footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  • 12.7 BRAND/PRODUCT COMPARISON
  • 12.8 R&D EXPENDITURE OF KEY PLAYERS
  • 12.9 COMPANY VALUATION AND FINANCIAL METRICS
    • 12.9.1 COMPANY VALUATION
    • 12.9.2 FINANCIAL METRICS
  • 12.10 COMPETITIVE SCENARIO
    • 12.10.1 PRODUCT APPROVALS/LAUNCHES
    • 12.10.2 DEALS
    • 12.10.3 EXPANSIONS
    • 12.10.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 ELANCO ANIMAL HEALTH INCORPORATED
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product launches and approvals
        • 13.1.1.3.2 Deals
        • 13.1.1.3.3 Expansions
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Right to win
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses and competitive threats
    • 13.1.2 MERCK & CO., INC
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Product launches and approvals
        • 13.1.2.3.2 Deals
        • 13.1.2.3.3 Expansions
        • 13.1.2.3.4 Other developments
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Right to win
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses and competitive threats
    • 13.1.3 VIRBAC
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Deals
        • 13.1.3.3.2 Expansions
        • 13.1.3.3.3 Other developments
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Right to win
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses and competitive threats
    • 13.1.4 ZOETIS INC.
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Product launches and approvals
        • 13.1.4.3.2 Deals
        • 13.1.4.3.3 Expansions
        • 13.1.4.3.4 Other developments
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Right to win
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses and competitive threats
    • 13.1.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Product approvals
        • 13.1.5.3.2 Deals
      • 13.1.5.4 MnM view
        • 13.1.5.4.1 Right to win
        • 13.1.5.4.2 Strategic choices
        • 13.1.5.4.3 Weaknesses and competitive threats
    • 13.1.6 VETOQUINOL
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Product approvals
    • 13.1.7 DECHRA PHARMACEUTICALS PLC
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Product approvals
        • 13.1.7.3.2 Deals
    • 13.1.8 HESTER BIOSCIENCES LIMITED
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products offered
    • 13.1.9 PETIQ, INC.
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Other developments
    • 13.1.10 OUROFINO SAUDE ANIMAL
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products offered
    • 13.1.11 SWEDENCARE
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products offered
      • 13.1.11.3 Recent developments
        • 13.1.11.3.1 Deals
    • 13.1.12 ORION CORPORATION
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products offered
    • 13.1.13 NORBROOK
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products offered
      • 13.1.13.3 Recent developments
        • 13.1.13.3.1 Product launches
        • 13.1.13.3.2 Expansions
    • 13.1.14 CEVA SANTE ANIMALE
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products offered
      • 13.1.14.3 Recent developments
        • 13.1.14.3.1 Deals
    • 13.1.15 BIMEDA, INC.
      • 13.1.15.1 Business overview
      • 13.1.15.2 Products offered
      • 13.1.15.3 Recent developments
        • 13.1.15.3.1 Product launches
        • 13.1.15.3.2 Deals
  • 13.2 OTHER PLAYERS
    • 13.2.1 INDIAN IMMUNOLOGICALS LTD.
    • 13.2.2 VETANCO
    • 13.2.3 CHANELLE PHARMA
    • 13.2.4 PEGASUS LABORATORIES, INC.
    • 13.2.5 KYORITSU SEIYAKU CORPORATION
    • 13.2.6 AVET HEALTH
    • 13.2.7 ANIMALDERMA SRLS
    • 13.2.8 LETI PHARMA
    • 13.2.9 HUVEPHARMA, INC.
    • 13.2.10 VETPLUS

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
  • TABLE 2 PET (DOGS AND CATS) OWNERSHIP STATISTICS IN US, 2024
  • TABLE 3 COMPANION ANIMAL POPULATION STATISTICS, BY REGION
  • TABLE 4 MAJOR OUTBREAKS OF ZOONOTIC DISEASES, 2022-2023
  • TABLE 5 AVERAGE ANNUAL PREMIUM: US AND CANADA (USD)
  • TABLE 6 VETERINARY DERMATOLOGY MARKET: IMPACT OF PORTER'S FIVE FORCES ANALYSIS
  • TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 VETERINARY DERMATOLOGY MARKET: LIST OF MAJOR PATENTS
  • TABLE 12 IMPORT DATA FOR PRODUCTS RELATED TO VETERINARY DERMATOLOGY, BY COUNTRY (2022-2024) (USD)
  • TABLE 13 EXPORT DATA FOR PRODUCTS RELATED TO VETERINARY DERMATOLOGY, BY COUNTRY (2022-2024) (USD)
  • TABLE 14 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY PRODUCT TYPE, 2022-2024
  • TABLE 15 AVERAGE SELLING PRICE OF VETERINARY DERMATOLOGY PRODUCT TYPES, BY REGION, 2022-2024
  • TABLE 16 VETERINARY DERMATOLOGY MARKET: KEY CONFERENCES AND EVENTS (2025-2026)
  • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE
  • TABLE 18 KEY BUYING CRITERIA FOR VETERINARY DERMATOLOGY PRODUCTS
  • TABLE 19 UNMET NEEDS/END USER EXPECTATIONS IN VETERINARY DERMATOLOGY MARKET
  • TABLE 20 VETERINARY DERMATOLOGY MARKET: IMPACT OF GENERATIVE AI
  • TABLE 21 VETERINARY DERMATOLOGY MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 22 VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 23 VETERINARY DERMATOLOGY MARKET: TOPICAL PRODUCTS AVAILABLE
  • TABLE 24 TOPICAL: VETERINARY DERMATOLOGY MARKET, BY COUNTRY/REGION, 2023-2030 (USD MILLION)
  • TABLE 25 VETERINARY DERMATOLOGY MARKET: INJECTABLE PRODUCTS AVAILABLE
  • TABLE 26 INJECTABLES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 27 VETERINARY DERMATOLOGY MARKET: ORAL PRODUCTS AVAILABLE
  • TABLE 28 ORAL: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 29 VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 30 VETERINARY DERMATOLOGY MARKET: ANTIPARASITIC DRUGS AVAILABLE
  • TABLE 31 VOLUME DATA FOR ANTIPARASITIC DRUGS: VETERINARY DERMATOLOGY MARKET, BY REGION, 2023-2030 (THOUSAND UNITS)
  • TABLE 32 ANTIPARASITIC DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 VETERINARY DERMATOLOGY MARKET: ANTIFUNGAL DRUGS AVAILABLE
  • TABLE 34 ANTIFUNGAL DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 VETERINARY DERMATOLOGY MARKET: ANTIBACTERIAL DRUGS AVAILABLE
  • TABLE 36 ANTIBACTERIAL DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 VETERINARY DERMATOLOGY MARKET: MONOCLONAL ANTIBODIES AVAILABLE
  • TABLE 38 MONOCLONAL ANTIBODIES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 VETERINARY DERMATOLOGY MARKET: OTHER PRODUCTS AVAILABLE
  • TABLE 40 OTHER PRODUCT TYPES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 42 PARASITIC INFECTIONS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 INFECTIOUS DISEASES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 AUTOIMMUNE SKIN DISEASES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 SKIN CANCER: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 46 OTHER CONDITION TYPES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 48 COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET, 2023-2030 (USD MILLION)
  • TABLE 49 COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 DOGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 CATS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 52 HORSES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 53 OTHER COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 LIVESTOCK ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 CATTLE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 SWINE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 POULTRY: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 58 OTHER LIVESTOCK ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 59 VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 60 VETERINARY HOSPITALS AND CLINICS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 61 ANIMAL SHELTERS AND RESCUES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 OTHER END USERS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 VETERINARY DERMATOLOGY MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 69 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 70 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 71 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 72 US: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 73 US: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 74 US: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 75 US: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 76 US: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 77 US: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 78 US: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 79 CANADA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 80 CANADA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 81 CANADA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 82 CANADA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 83 CANADA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 84 CANADA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 85 CANADA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 86 EUROPE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 87 EUROPE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 88 EUROPE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 89 EUROPE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 90 EUROPE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 91 EUROPE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 92 EUROPE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 93 EUROPE: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 94 GERMANY: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 95 GERMANY: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 96 GERMANY: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 97 GERMANY: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 98 GERMANY: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 99 GERMANY: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 100 GERMANY: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 101 UK: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 102 UK: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 103 UK: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 104 UK: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 105 UK: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 106 UK: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 107 UK: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 108 FRANCE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 109 FRANCE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 110 FRANCE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 111 FRANCE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 112 FRANCE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 113 FRANCE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 114 FRANCE: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 115 ITALY: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 116 ITALY: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 117 ITALY: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 118 ITALY: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 119 ITALY: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 120 ITALY: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 121 ITALY: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 122 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 123 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 124 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 125 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 126 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 127 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 128 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 129 SPAIN: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 130 SPAIN: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 131 SPAIN: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 132 SPAIN: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 133 SPAIN: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 134 SPAIN: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 135 SPAIN: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 136 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 137 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 138 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 139 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 140 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 141 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 142 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 151 JAPAN: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 152 JAPAN: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 153 JAPAN: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 154 JAPAN: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 155 JAPAN: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 156 JAPAN: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 157 JAPAN: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 158 CHINA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 159 CHINA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 160 CHINA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 161 CHINA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 162 CHINA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 163 CHINA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 164 CHINA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 165 INDIA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 166 INDIA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 167 INDIA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 168 INDIA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 169 INDIA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 170 INDIA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 171 INDIA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 172 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 173 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 174 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 175 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 176 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 177 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 178 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 179 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 180 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 181 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 182 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 183 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 184 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 185 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 186 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 187 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 188 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 189 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 190 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 191 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 192 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 193 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 194 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 195 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 196 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 197 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 198 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 199 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 200 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 201 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 202 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 203 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 204 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 205 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 206 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 207 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 208 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 209 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 210 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 211 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 212 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 213 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 214 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 215 MEXICO: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 216 MEXICO: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 217 MEXICO: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 218 MEXICO: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 219 MEXICO: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 220 MEXICO: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 221 MEXICO: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 222 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 223 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 224 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 225 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 226 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 227 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 228 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 229 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 230 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 231 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 232 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 233 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 234 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 235 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 236 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 237 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 238 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 239 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 240 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 241 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 242 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 243 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 244 KSA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 245 KSA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 246 KSA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 247 KSA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 248 KSA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 249 KSA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 250 KSA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 251 UAE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 252 UAE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 253 UAE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 254 UAE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 255 UAE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 256 UAE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 257 UAE: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 258 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 259 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 260 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 261 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 262 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 263 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 264 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 265 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 266 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 267 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023-2030 (USD MILLION)
  • TABLE 268 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 269 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 270 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023-2030 (USD MILLION)
  • TABLE 271 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 272 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET
  • TABLE 273 VETERINARY DERMATOLOGY MARKET: DEGREE OF COMPETITION
  • TABLE 274 VETERINARY DERMATOLOGY MARKET: REGION FOOTPRINT
  • TABLE 275 VETERINARY DERMATOLOGY MARKET: ROUTE OF ADMINISTRATION FOOTPRINT
  • TABLE 276 VETERINARY DERMATOLOGY MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 277 VETERINARY DERMATOLOGY MARKET: CONDITION TYPE FOOTPRINT
  • TABLE 278 VETERINARY DERMATOLOGY MARKET: ANIMAL TYPE FOOTPRINT
  • TABLE 279 VETERINARY DERMATOLOGY MARKET: LIST OF KEY STARTUPS/SMES
  • TABLE 280 VETERINARY DERMATOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 281 VETERINARY DERMATOLOGY MARKET: PRODUCT APPROVALS/LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 282 VETERINARY DERMATOLOGY MARKET: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 283 VETERINARY DERMATOLOGY MARKET: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 284 VETERINARY DERMATOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 285 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY OVERVIEW
  • TABLE 286 ELANCO ANIMAL HEALTH INCORPORATED: PRODUCTS OFFERED
  • TABLE 287 ELANCO ANIMAL HEALTH INCORPORATED: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 288 ELANCO ANIMAL HEALTH INCORPORATED: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 289 ELANCO ANIMAL HEALTH INCORPORATED: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 290 MERCK & CO., INC: COMPANY OVERVIEW
  • TABLE 291 MERCK & CO., INC: PRODUCTS OFFERED
  • TABLE 292 MERCK & CO., INC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 293 MERCK & CO., INC: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 294 MERCK & CO., INC: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 295 MERCK & CO., INC: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 296 VIRBAC: COMPANY OVERVIEW
  • TABLE 297 VIRBAC: PRODUCTS OFFERED
  • TABLE 298 VIRBAC: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 299 VIRBAC: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 300 VIRBAC: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 301 ZOETIS INC.: COMPANY OVERVIEW
  • TABLE 302 ZOETIS INC.: PRODUCTS OFFERED
  • TABLE 303 ZOETIS INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 304 ZOETIS INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 305 ZOETIS INC.: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 306 ZOETIS INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 307 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW
  • TABLE 308 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED
  • TABLE 309 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 310 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 311 VETOQUINOL: COMPANY OVERVIEW
  • TABLE 312 VETOQUINOL: PRODUCTS OFFERED
  • TABLE 313 VETOQUINOL: PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 314 DECHRA PHARMACEUTICALS PLC: COMPANY OVERVIEW
  • TABLE 315 DECHRA PHARMACEUTICALS PLC: PRODUCTS OFFERED
  • TABLE 316 DECHRA PHARMACEUTICALS PLC: PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 317 DECHRA PHARMACEUTICALS PLC: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 318 HESTER BIOSCIENCES LIMITED: COMPANY OVERVIEW
  • TABLE 319 HESTER BIOSCIENCES LIMITED: PRODUCTS OFFERED
  • TABLE 320 PETIQ, INC.: COMPANY OVERVIEW
  • TABLE 321 PETIQ, INC.: PRODUCTS OFFERED
  • TABLE 322 PETIQ, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 323 OUROFINO SAUDE ANIMAL: COMPANY OVERVIEW
  • TABLE 324 OUROFINO SAUDE ANIMAL: PRODUCTS OFFERED
  • TABLE 325 SWEDENCARE: COMPANY OVERVIEW
  • TABLE 326 SWEDENCARE: PRODUCTS OFFERED
  • TABLE 327 SWEDENCARE: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 328 ORION CORPORATION: COMPANY OVERVIEW
  • TABLE 329 ORION CORPORATION: PRODUCTS OFFERED
  • TABLE 330 NORBROOK: COMPANY OVERVIEW
  • TABLE 331 NORBROOK: PRODUCTS OFFERED
  • TABLE 332 NORBROOK: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 333 NORBROOK: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 334 CEVA SANTE ANIMALE: COMPANY OVERVIEW
  • TABLE 335 CEVA SANTE ANIMALE: PRODUCTS OFFERED
  • TABLE 336 CEVA SANTE ANIMALE: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 337 BIMEDA, INC.: COMPANY OVERVIEW
  • TABLE 338 BIMEDA, INC.: PRODUCTS OFFERED
  • TABLE 339 BIMEDA, INC.: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 340 BIMEDA, INC.: DEALS, JANUARY 2021-JANUARY 2025

List of Figures

  • FIGURE 1 VETERINARY DERMATOLOGY MARKET SCOPE AND REGIONS COVERED
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION
  • FIGURE 8 REVENUE ESTIMATION APPROACH: ZOETIS INC.
  • FIGURE 9 VETERINARY DERMATOLOGY MARKET (2024): SUPPLY-SIDE ANALYSIS
  • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2030)
  • FIGURE 11 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
  • FIGURE 12 TOP-DOWN APPROACH
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 VETERINARY DERMATOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 VETERINARY DERMATOLOGY MARKET FOR COMPANION ANIMALS, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 VETERINARY DERMATOLOGY MARKET FOR LIVESTOCK ANIMALS, 2025 VS. 2030 (USD MILLION)
  • FIGURE 20 VETERINARY DERMATOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 21 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 22 RISING PET POPULATION AND OWNERSHIP TO DRIVE VETERINARY DERMATOLOGY MARKET
  • FIGURE 23 ANTIPARASITIC DRUGS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, IN 2024
  • FIGURE 24 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 25 NEW ZEALAND TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 26 DEVELOPED MARKETS TO REGISTER HIGHER GROWTH THAN EMERGING MARKETS DURING FORECAST PERIOD
  • FIGURE 27 VETERINARY DERMATOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 28 PET POPULATION IN MAJOR MARKETS IN 2022 (MILLION)
  • FIGURE 29 EUROPE: PET POPULATION, 2021-2023
  • FIGURE 30 TOTAL INSURED PETS IN US, 2019-2023
  • FIGURE 31 TOTAL INSURED PETS IN CANADA, 2019-2023
  • FIGURE 32 TOTAL NUMBER OF VETERINARIANS IN US, BY GENDER, 2020-2023
  • FIGURE 33 NUMBER OF VETERINARIANS IN TOP 5 EUROPEAN COUNTRIES, 2023
  • FIGURE 34 VETERINARY DERMATOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 35 DEVELOPMENT & APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS
  • FIGURE 36 PATENT PUBLICATION TRENDS, JANUARY 2014-DECEMBER 2024
  • FIGURE 37 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY DERMATOLOGY PATENTS (JANUARY 2014-DECEMBER 2024)
  • FIGURE 38 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DERMATOLOGY PATENTS (JANUARY 2014-DECEMBER 2024)
  • FIGURE 39 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY PRODUCT TYPE, 2022-2024
  • FIGURE 40 AVERAGE SELLING PRICE OF VETERINARY DERMATOLOGY PRODUCT TYPES, BY REGION, 2024
  • FIGURE 41 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE
  • FIGURE 42 KEY BUYING CRITERIA FOR VETERINARY DERMATOLOGY PRODUCTS
  • FIGURE 43 VETERINARY DERMATOLOGY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 44 VETERINARY DERMATOLOGY MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 45 VETERINARY DERMATOLOGY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 46 ADJACENT MARKETS FOR VETERINARY DERMATOLOGY MARKET
  • FIGURE 47 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS IN VETERINARY DERMATOLOGY MARKET
  • FIGURE 48 INVESTMENT AND FUNDING ACTIVITIES IN VETERINARY DERMATOLOGY MARKET, 2020-2024
  • FIGURE 49 VETERINARY DERMATOLOGY MARKET, 2025-2030
  • FIGURE 50 GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA
  • FIGURE 51 NORTH AMERICA: PET POPULATION, 2024
  • FIGURE 52 NORTH AMERICA: NUMBER OF VETERINARIANS, 2023
  • FIGURE 53 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET SNAPSHOT
  • FIGURE 54 US: TOTAL PET HEALTH EXPENDITURE (2018-2024)
  • FIGURE 55 EUROPE: PET POPULATION (MILLION), 2023
  • FIGURE 56 EUROPE: NUMBER OF VETERINARIANS, 2022
  • FIGURE 57 ASIA PACIFIC: DOG POPULATION, BY COUNTRY, 2024
  • FIGURE 58 ASIA PACIFIC: CAT POPULATION, BY COUNTRY, 2024
  • FIGURE 59 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET SNAPSHOT
  • FIGURE 60 LATIN AMERICA: PET POPULATION, 2022
  • FIGURE 61 MIDDLE EAST & AFRICA: CAT POPULATION, 2024
  • FIGURE 62 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2020-2024)
  • FIGURE 63 SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2024)
  • FIGURE 64 RANKING OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET, 2024
  • FIGURE 65 VETERINARY DERMATOLOGY MARKET: COMPANY EVALUATION MATRIX, 2024
  • FIGURE 66 VETERINARY DERMATOLOGY MARKET: COMPANY FOOTPRINT, 2024
  • FIGURE 67 VETERINARY DERMATOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 68 VETERINARY DERMATOLOGY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 69 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET, 2021-2023
  • FIGURE 70 EV/EBITDA FOR TOP COMPANIES
  • FIGURE 71 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 72 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2024)
  • FIGURE 73 MERCK & CO., INC: COMPANY SNAPSHOT (2024)
  • FIGURE 74 VIRBAC: COMPANY SNAPSHOT (2023)
  • FIGURE 75 ZOETIS INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 76 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2023)
  • FIGURE 77 VETOQUINOL: COMPANY SNAPSHOT (2023)
  • FIGURE 78 DECHRA PHARMACEUTICALS PLC: COMPANY SNAPSHOT (2023)
  • FIGURE 79 HESTER BIOSCIENCES LIMITED: COMPANY SNAPSHOT (2023)
  • FIGURE 80 PETIQ, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 81 OUROFINO SAUDE ANIMAL: COMPANY SNAPSHOT (2023)
  • FIGURE 82 SWEDENCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 83 ORION CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 84 NORBROOK: COMPANY SNAPSHOT (2023)